Skip to content
2000
Volume 22, Issue 5
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

We describe herein the therapeutic targets involved in Alzheimer’s disease as well as the available drugs and their synthetic routes. Bioactive compounds under development are also exploited to illustrate some recent research advances on the medicinal chemistry of Alzheimer’s disease, including structure-activity relationships for some targets. The importance of multi-target approaches, including some examples from our research projects, guides new perspectives in search of more effective drug candidates. This review comprises the period between 2001 and early 2020.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450121999200819144544
2021-04-01
2025-10-26
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450121999200819144544
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test